Cargando…

Clinical outcomes of nonvitamin K oral anticoagulants and acenocoumarol for stroke prevention in contemporary practice: A population‐based propensity‐weighted cohort study

AIMS: Acenocoumarol is a vitamin‐K antagonist (VKA) primarily used in certain countries (e.g. India, Netherlands, Spain). The half‐life of acenocoumarol is similar to that of non‐VKA oral anticoagulants (NOAC), unlike warfarin, and this could affect comparative effectiveness and safety (CES). Howeve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodríguez‐Bernal, Clara L., Santa‐Ana‐Téllez, Yared, García‐Sempere, Aníbal, Hurtado, Isabel, Peiró, Salvador, Sanfélix‐Gimeno, Gabriel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328430/ https://www.ncbi.nlm.nih.gov/pubmed/32530052 http://dx.doi.org/10.1111/bcp.14430

Ejemplares similares

Estimating Adherence Based on Prescription or Dispensation Information: Impact on Thresholds and Outcomes. A Real-World Study With Atrial Fibrillation Patients Treated With Oral Anticoagulants in Spain
por: Hurtado-Navarro, Isabel, et al.
Publicado: (2018)

Real-world adherence to oral anticoagulants in atrial fibrillation patients: a study protocol for a systematic review and meta-analysis
por: Rodríguez-Bernal, Clara L, et al.
Publicado: (2018)

Quality of INR control and switching to non-Vitamin K oral anticoagulants between women and men with atrial fibrillation treated with Vitamin K Antagonists in Spain. A population-based, real-world study
por: García-Sempere, Aníbal, et al.
Publicado: (2019)

Oral Anticoagulants Initiation in Patients with Atrial Fibrillation: Real-World Data from a Population-Based Cohort
por: Rodríguez-Bernal, Clara L., et al.
Publicado: (2017)

Primary Nonadherence to Oral Anticoagulants in Patients with Atrial Fibrillation: Real-World Data from a Population-Based Cohort
por: Rodriguez-Bernal, Clara L., et al.
Publicado: (2018)

Group-based Trajectory Models to Assess Quality of INR Control and Its Association With Clinical Outcomes
por: García-Sempere, Aníbal, et al.
Publicado: (2020)

Trends and Geographical Variability in Osteoporosis Treatment After Hip Fracture: A Multilevel Analysis of 30,965 Patients in the Region of Valencia, Spain
por: Hurtado, Isabel, et al.
Publicado: (2020)

Predictive Performance of the FRAX Tool Calibrated for Spain vs. an Age and Sex Model: Prospective Cohort Study with 9082 Women and Men Followed for up to 8 Years
por: García-Sempere, Aníbal, et al.
Publicado: (2022)

Impact of Drug Safety Warnings and Cost-Sharing Policies on Osteoporosis Drug Utilization in Spain: A Major Reduction But With the Persistence of Over and Underuse. Data From the ESOSVAL Cohort From 2009 to 2015
por: Hurtado-Navarro, Isabel, et al.
Publicado: (2019)

Association of Vitamin K and Non‐Vitamin K Oral Anticoagulant Use and Cancer Incidence in Atrial Fibrillation Patients
por: Iftimi, Adina A., et al.
Publicado: (2021)

Increasing Trends in Opioid Use From 2010 to 2018 in the Region of Valencia, Spain: A Real-World, Population-Based Study
por: Hurtado, Isabel, et al.
Publicado: (2020)

A Multilevel Analysis of Real-World Variations in Oral Anticoagulation Initiation for Atrial Fibrillation in Valencia, a European Region
por: García-Sempere, Aníbal, et al.
Publicado: (2017)

Primary and secondary non-adherence to osteoporotic medications after hip fracture in Spain. The PREV2FO population-based retrospective cohort study
por: García-Sempere, Aníbal, et al.
Publicado: (2017)

Cost‐Sharing Increase, Medication Adherence, and Hospitalizations in Schizophrenia Patients: A Natural Experiment
por: Serra‐Burriel, Miquel, et al.
Publicado: (2021)

Incidence of Subsequent Hip Fracture and Mortality in Elderly Patients: A Multistate Population‐Based Cohort Study in Eastern Spain
por: Llopis‐Cardona, Fran, et al.
Publicado: (2022)

Assessing Concurrent Adherence to Combined Essential Medication and Clinical Outcomes in Patients With Acute Coronary Syndrome. A Population-Based, Real-World Study Using Group-Based Trajectory Models
por: Rodríguez-Bernal, Clara L., et al.
Publicado: (2022)

Real-world patterns of opioid therapy initiation in Spain, 2012–2018: A population-based, retrospective cohort study with 957,080 patients and 1,509,488 initiations
por: Hurtado, Isabel, et al.
Publicado: (2022)

Real-World Patterns of Pharmacotherapeutic Management of Asthma Patients With Exacerbations in the Spanish National Health System
por: Hurtado, Isabel, et al.
Publicado: (2020)

Impact of Three Safety Interventions Targeting Off-Label Use of Immediate-Release Fentanyl on Prescription Trends: Interrupted Time Series Analysis
por: García-Sempere, Aníbal, et al.
Publicado: (2022)

Overuse and Underuse of Antiosteoporotic Treatments According to Highly Influential Osteoporosis Guidelines: A Population-Based Cross-Sectional Study in Spain
por: Sanfélix-Gimeno, Gabriel, et al.
Publicado: (2015)

Data Resource Profile: The Valencia Health System Integrated Database (VID)
por: García-Sempere, Anibal, et al.
Publicado: (2020)

Variations in osteoporosis medication utilization. A population-based ecological cross-sectional study in the region of Valencia, Spain
por: Sanfélix-Gimeno, Gabriel, et al.
Publicado: (2018)

Impact of osteoporosis and vertebral fractures on quality-of-life. a population-based study in Valencia, Spain (The FRAVO Study)
por: Sanfélix-Genovés, José, et al.
Publicado: (2011)

Adherence to oral anticoagulants in patients with atrial fibrillation—a population-based retrospective cohort study linking health information systems in the Valencia region, Spain: a study protocol
por: Sanfélix-Gimeno, G, et al.
Publicado: (2015)

Side effects during the week after first dose vaccination with four Covid-19 vaccines. Results of the ProVaVac Survey Study with 13,837 people in Spain
por: Sánchez-Saez, Francisco, et al.
Publicado: (2022)

Nonvitamin K antagonist oral anticoagulants (NOACs): the tide continues to come in
por: Blann, Andrew
Publicado: (2015)

Nonvitamin K antagonist oral anticoagulant activity: challenges in measurement and reversal
por: Brown, Karen S., et al.
Publicado: (2016)

Tooth extraction in patients taking nonvitamin K antagonist oral anticoagulants
por: Morimoto, Yoshinari, et al.
Publicado: (2016)

Nonvitamin K antagonist oral anticoagulant use in patients with renal impairment
por: Turpie, Alexander G.G., et al.
Publicado: (2017)

Nonvitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients and Risk of Dementia: A Nationwide Propensity‐Weighted Cohort Study
por: Søgaard, Mette, et al.
Publicado: (2019)

Variation in Antiosteoporotic Drug Prescribing and Spending Across Spain. A Population-Based Ecological Cross-Sectional Study
por: Sanfélix-Gimeno, Gabriel, et al.
Publicado: (2018)

Medication Adherence Patterns after Hospitalization for Coronary Heart Disease. A Population-Based Study Using Electronic Records and Group-Based Trajectory Models
por: Librero, Julián, et al.
Publicado: (2016)

Preventive Strategies against Bleeding due to Nonvitamin K Antagonist Oral Anticoagulants
por: Sarah, Lessire, et al.
Publicado: (2014)

Helsinki experience on nonvitamin K oral anticoagulants for treating cervical artery dissection
por: Mustanoja, Satu, et al.
Publicado: (2015)

Development and validation of a population-based prediction scale for osteoporotic fracture in the region of Valencia, Spain: the ESOSVAL-R study
por: Sanfélix-Genovés, José, et al.
Publicado: (2010)

Impact of a multifaceted intervention to improve the clinical management of osteoporosis. The ESOSVAL-F study
por: Sanfélix-Genovés, José, et al.
Publicado: (2010)

Primary care doctors’ views on self-monitoring of blood pressure and self-titration among patients with uncontrolled hypertension in Spain. The ADAMPA trial focus group study.
por: Marco-Moreno, Irene, et al.
Publicado: (2020)

Effect of cost sharing on adherence to evidence-based medications in patients with acute coronary syndrome
por: González López-Valcárcel, Beatriz, et al.
Publicado: (2017)

Erratum to “Preventive Strategies against Bleeding due to Nonvitamin K Antagonist Oral Anticoagulants”
por: Lessire, Sarah, et al.
Publicado: (2014)

The change of renal functions after nonvitamin K oral anticoagulants in patients with atrial fibrillation
por: Chantrarat, Thoranis, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0gsnk1rbmpfsq36hgveg7p9gvh